Unravelling the Influence of Demographic and Lifestyle Factors on Monocyte Chemoattractant Protein-1 in Diabetic Retinopathy Patients
DOI:
https://doi.org/10.51985/JBUMDC2023179Keywords:
Diabetic Retinopathy, Exercise, Gender, Monocyte Chemoattractant Protein-1, Smoking.Abstract
Objectives: To determine the association of Monocyte chemoattractant protein-1 (MCP-1) level with Age, blood glucose
level, Exercise, Gender and Smoking in diabetic retinopathy patients.
Study Design and settings: A case-control study was carried in the physiology department at the Jinnah Postgraduate
Medical Centre in Karachi From April 2019 to October 2020.
Methodology: One hundred people were divided into four groups which were; Group D (n=25) were healthy normal
individuals; Group C (n=25) diabetic patient's with moderate retinopathy; Group B (n=25) diabetic patient's with mild
retinopathy while Group A (n=25) diabetic patients with no retinopathy. Every participant was checked for blood sugar
level, retinoscopy through slit lamp examination and serum MCP-1 level. The association was made between diabetic
retinopathy, MCP-1 protein levels, age, gender, smoking and exercise.
Results: MCP-1 levels are significantly greater in diabetic males with moderate retinopathy compared to diabetic females
with moderate retinopathy (p-value 0.042). Similarly, smoking is associated with the elevation of MCP-1 levels in diabetic
patients with moderate retinopathy (p-value 0.05). Exercise has no significant effect on MCP-1 levels in all groups. An
increase in age, HbA1C, fasting and random blood glucose levels were significantly correlated with MCP-1 levels ( pvalue 0.000)
Conclusion: It is concluded from the study that an advance in age and an increase in blood glucose level are associated
with an increased level of MCP-1 protein. Moreover, Male gender and smoking are also associated with enhanced MCP-
1 levels in diabetic patients with moderate retinopathy.
References
Tatsumi Y, Ohkubo T. Hypertension with diabetes mellitus:
significance from an epidemiological perspective for Japanese.
Hypertension Res. 2017; 40(9): 795-806. DOI: https://doi:org/
1038/hr.2017.67.
Glovaci D, Fan W, Wong ND. Epidemiology of diabetes
mellitus and cardiovascular disease. Curr Cardiol Rep. 2019;
: 1-8. DOI: https://doi.org/10.1007/s11886-019-1107-y.
Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ. Update in
the epidemiology, risk factors, screening, and treatment of
diabetic retinopathy. Journal of diabetes investigation. 2021;
(8): 1322-5. DOI: https://doi.org/10.1111/jdi.13480.
Nanayakkara N, Curtis AJ, Heritier S, Gadowski AM, Pavkov
ME, Kenealy T et al. Impact of age at type 2 diabetes mellitus
diagnosis on mortality and vascular complications: systematic
review and meta-analyses. Diabetologia. 2021; 64: 275-87.
DOI: https://doi.org/10.1007/s00125-020-05319-w.
Stitt AW, Curtis TM, Chen M, Medina RJ, McKay GJ, Jenkins
A et al. The progress in understanding and treatment of diabetic
retinopathy. Progress in retinal and eye research. 2016; 51(2):
-86. DOI: https://doi.org/10.1016/j.preteyeres.2015.08.001.
Nentwich MM, Ulbig MW. Diabetic retinopathy-ocular
complications of diabetes mellitus. WJD. 2015; 6(3): 489-
DOI: https://doi: 10.4239/wjd.v6.i3.489.
Ting DS, Cheung GC, Wong TY. Diabetic retinopathy: global
prevalence, major risk factors, screening practices and public
health challenges: a review. Clin. Experiment. Ophthalmol.
; 44(4): 260-277. DOI: https://doi.org/10.1111/ceo.12696.
Ipp E, Kumar M. A clinical conundrum: intensifying glycemic
control in the presence of advanced diabetic retinopathy.
Diabetes Care. 2021; 44(10): 2192–2193. DOI: https://doi.org/
2337/dci21-0029.
Taghavi Y, Hassanshahi G, Kounis NG, Koniari I,
Khorramdelazad H. Monocyte chemoattractant protein-1
(MCP-1/CCL2) in diabetic retinopathy: latest evidence and
clinical considerations. J Cell Commun Signal. 2019; 13(4):
-462. DOI: https://doi.org/10.1007/s12079-018-00500-8.
Noma H, Yasuda K, Shimura M. Cytokines and pathogenesis
of central retinal vein occlusion. J Clin Med. 2020; 9(11):
DOI: https://doi.org/10.3390/jcm9113457.
Mahmoud AA, Soliman MS, Moustafa A. Evaluation of
monocyte chemoattractant protein 1 (MCP-1) as a predictor
of complications in type 2 diabetes mellitus in Zagazig
University Hospital. The Egyptian Journal of Hospital
Medicine. 2021; 83(1): 995-1001. DOI: https://doi.org/10.
/ EJHM.2021.160038.
Vujosevic Stela, Muraca Andrea, Alkabes Micol, Villani
Edoardo, Cavarzeran Fabiano, Rossetti Luca et al. Early
microvascular and neural changes in patients with type 1 and
type 2 diabetes mellitus without clinical signs of diabetic
retinopathy. Retina.2019; 39(3): 435-445. DOI: https://doi:
1097/IAE.0000000000001990.
Reddy S, Amutha A, Rajalakshmi R, Bhaskaran R, Monickaraj
F, Rangasamy S et al. Association of increased levels of MCP-
and cathepsin-D in young onset type 2 diabetes patients
(T2DM-Y) with severity of diabetic retinopathy. JDC. 2017;
(5): 804-809. DOI: https://doi.org/10.1016/ j.jdiacomp.
02.017.
Behfar S, Hassanshahi G, Nazari A, Khorramdelazad H. A
brief look at the role of monocyte chemoattractant protein-1
(CCL2) in the pathophysiology of psoriasis. Cytokine. 2018;
(1): 226-231. DOI: https://doi.org/10.1016/ j.cyto.2017.
010.
Urbanèiè M, Petroviè D, Živin AM, Korošec P, Fležar M,
Petroviè MG. Correlations between vitreous cytokine levels
and inflammatory cells in fibrovascular membranes of patients
with proliferative diabetic retinopathy. Molecular vision.
;26:472.
Wang W, Lo AC. Diabetic retinopathy: pathophysiology and
treatments. Int. J. Mol. Sci. 2018; 19(6): 1816. DOI: https://doi.
org/10.3390/ijms19061816.
de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson
CM, Antman EM et al. Association between plasma levels of
monocyte chemoattractant protein-1 and long-term clinical
outcomes in patients with acute coronary syndromes.
Circulation. 2003; 107(5): 690-5. DOI: https://doi.org/10.1161/
CIR.0000049742.68848.99.
Komiyama M, Takanabe R, Ono K, Shimada S, Wada H,
Yamakage H et al. Association between monocyte
chemoattractant protein-1 and blood pressure in smokers. J
Int Med Res. 2018; 46(3): 965-974. DOI: https://doi/10.1177/
Feng D, Liu T, Su DF, Wang H, Ding P, He YH et al. The
association between smoking quantity and hypertension
mediated by inflammation in Chinese current smokers. Journal
of hypertension. 2013; 31(9): 1798-805. DOI: https://doi:10.
/ HJH.0b013e328362c21a.
Dekker Nitert M, Barrett HL, Denny KJ, McIntyre HD,
Callaway LK, BAMBINO group. Exercise in pregnancy does
not alter gestational weight gain, MCP-1 or leptin in obese
women. Australian and New Zealand Journal of Obstetrics
and Gynaecology. 2015; 55(1): 27-33. DOI: https://doi.org/
1111/ajo.12300.
Marius Trøseid, Knut T Lappegård, Tor Claudi, Jan K Damås,
Lars Mørkrid, Randi Brendberg et al. Exercise reduces plasma
levels of the chemokines MCP-1 and IL-8 in subjects with
the metabolic syndrome. European Heart Journal.2004; 25
(4): 349–355. DOI: https://doi.org/10.1016/j.ehj.2003.12.006.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Shabeer Ahmed, Hammad Raziq, Noman Sadiq, Sana Soomro, Rubina Amjad, Wazir Ahmed Baloch
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
